Table 2.
Efficacy According to Different Early CRP Kinetics
Flare-Responder N=29 |
Responder N=45 |
Non-Responder N=58 |
p value | |
---|---|---|---|---|
Overall survival | ||||
Median (95% CI), months | – | 20.6 (15.5–25.7) | 10.0 (3.1–16.9) | <0.001 |
Progression-free survival | ||||
Median (95% CI), months | 11.6 (7.5–15.7) | 5.2 (2.3–8.1) | 2.3 (1.1–3.6) | <0.001 |
Best radiological response | ||||
CR | 3 (10.3%) | 1(2.2%) | 0 (0.0%) | |
PR | 9 (31.1%) | 5(11.1%) | 2 (3.5%) | |
PD | 6 (20.7%) | 14 (31.1%) | 30 (51.7%) | |
SD | 11 (37.9%) | 25 (55.6%) | 26 (44.8%) | |
ORR (CR+PR) | 12 (41.4%) | 6(13.3%) | 2 (3.5%) | <0.001 |
DCR (CR+PR+SD) | 23 (79.3%) | 31 (68.9%) | 28 (48.3%) | <0.001 |
Abbreviations: CI, confidence interval; CR, complete response; PR, partial response; PD, progressive disease; SD, stable disease; ORR, objective response rate; DCR, disease control rate.